Hemoglobin E Syndromes

Author:

Vichinsky Elliott

Abstract

Abstract Hemoglobin (Hb) E is one of the world’s most common and important mutations. It results in a heterogeneous group of disorders whose phenotype range from asymptomatic to severe. Hb E trait and Hb EE are mild disorders. The combination of Hb E and Hb S (Hb SE) results in a sickle cell disease syndrome similar to sickle β+ thalassemia. It is important to distinguish Hb E disorders diagnostically because of this marked difference in clinical course among different genotypes. Screening tests, including hemoglobin electrophoresis and high-pressure liquid chromatography (HPLC), may suggest other mutations, unless one is familiar with the findings. E β-thalassemia, the most serious form of E syndromes, affects a million people worldwide and is increasing in North America. Its phenotype ranges from mild anemia to severe transfusion-dependent thalassemia major. Several genetic modifiers affect the phenotype, including the type of β-thalassemia mutation, Hb F levels, and co-inheritance of α-thalassemia. However, the cause of the phenotypic variability is largely unknown. A prospective natural history study of E β-thalassemia in Sri Lanka suggests that environmental modifiers are prognostically important. The clinical course of E β-thalassemia is punctuated by acute and chronic complications that may cause serious morbidity and mortality. Recent studies indicate these patients are at high risk for thromboembolism secondary to a hypercoagulable state increased by splenectomy. Morbidity from iron overload in nontransfused patients secondary to increased gastrointestinal iron absorption is common. Cardiopulmonary disease, including pulmonary hypertension, requires ongoing monitoring and is secondary to iron overload, thromboembolism, and hemolysis-induced nitric oxide deficiency. These patients are excellent candidates for Hb F–modulating agents because moderate changes in hemoglobin may result in marked improvement in phenotype. Recent studies with hydroxyurea indicate 40% of patients will clinically improve with hydroxyurea.

Publisher

American Society of Hematology

Subject

Hematology

Reference42 articles.

1. Gibbons R, Higgs DR, Olivieri NF, Wood WG. The β and δ β thalassaemias in association with structural haemoglobin variants. In: Weatherall DJ, Clegg JB, eds. The Thalassaemia Syndromes (Fourth ed). Oxford, United Kingdom: Blackwell Science; 2001:393–449.

2. Old JM, Olivieri NF, Thien SL. Avoidance and population control. In: Weatherall DJ, Clegg JB, eds. The Thalassaemia Sydromes. United Kingdom: Blackwell Science; 2001:597–629.

3. de Silva S, Fisher CA, Premawardhena A, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet. 2000;355:786–791.

4. Weatherall DJ. Introduction to the problem of hemoglobin EB thalassemia. J Pediatr Hematol Oncol. 2000;22:551.

5. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, et al. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood. 2002;100:1172–1176.

Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Haematological Diseases in the Tropics;Manson's Tropical Diseases;2024

2. Molecular understanding of unusual HbE-β + -thalassemia with Hb phenotype similar to HbE heterozygote: simple and rapid differentiation using HbE levels;Annals of Medicine;2023-10-10

3. Spectrum of Adrenal Dysfunction in Hemoglobin E/Beta Thalassemia;The Journal of Clinical Endocrinology & Metabolism;2023-09-29

4. Severe homozygous HbE disease: the first case report from Nepal;Oxford Medical Case Reports;2023-06-01

5. KB Conundrum;Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3